Evolus (EOLS) FCF Margin Growth (3y) (2022 - 2026)
Evolus (EOLS) FCF Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | 2,259.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,259.00 |
| Mar 31, 2026 | 3,626.00 |
| Dec 31, 2025 | 3,553.00 |
| Sep 30, 2025 | 2,831.00 |
| Jun 30, 2025 | 1,750.00 |
| Mar 31, 2025 | 8,941.00 |
| Dec 31, 2024 | 2,999.00 |
| Sep 30, 2024 | 11,368.00 |
| Jun 30, 2024 | -7,302.00 |
| Mar 31, 2024 | 4,983.00 |
| Dec 31, 2023 | 1,170.00 |
| Sep 30, 2023 | 6,695.00 |
| Jun 30, 2023 | 16,772.00 |
| Mar 31, 2023 | 21,798.00 |
| Dec 31, 2022 | 5,978.00 |
| Sep 30, 2022 | 13,933.00 |
| Jun 30, 2022 | 139,250.00 |